Nivolumab Supplier-Buyer Network — Trade Flow Analysis

Name: Nivolumab Supplier-Buyer Trade Network Dataset — 23+ Indian Exporters, 13+ Importers, 13+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Nivolumab supplier network, Nivolumab buyers, pharmaceutical export India, Nivolumab trade data

TransData Nexus

Nivolumab

India Pharmaceutical Trade Intelligence

$2.3M23 Suppliers13 CountriesHS 30049099

ExportsIndia → SINGAPORE46.0%India → RUSSIA33.9%

ImportsUNITED STATES → India$48.1B SWITZERLAND → India$15.1M

Who Supplies Nivolumab? Top Manufacturers & Buyers 2026 — DR.REDDY'S LABORATORIES LTD Leads | TransData Nexus | TransData Nexus

1DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the first-largest Nivolumab exporter from India, with a market share of 46.0% and a total export value of $1.1M across 15 shipments. Their average shipment value of $70.1K is above the market average of $15.9K, suggesting premium or bulk contract pricing.

DR.REDDY'S LABORATORIES LTD serves 1 named buyer in our database. ALMAC PHARMACEUTICAL SERVICES PTE LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• ALMAC PHARMACEUTICAL SERVICES PTE LIMITED — $1.1M across 15 shipments (100.0% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $70.1K is 342% above the market average of $15.9K, consistent with large-order contracts or value-added formulations.

2CORSANTRUM TECHNOLOGY

CORSANTRUM TECHNOLOGY is the second-largest Nivolumab exporter from India, with a market share of 25.3% and a total export value of $577.3K across 22 shipments. Their average shipment value of $26.2K is above the market average of $15.9K, suggesting premium or bulk contract pricing.

CORSANTRUM TECHNOLOGY serves 5 named buyers in our database. COREX LLC is the dominant customer, accounting for 96.2% of this supplier's tracked business. Top customers include:

• COREX LLC — $555.6K across 21 shipments (96.2% of this supplier's total exports)

• LABCORP EARLY DEVELO — $20.9K across 1 shipments (3.6% of this supplier's total exports)

• BIOPHARMASPEC INC — $525 across 0 shipments (0.1% of this supplier's total exports)

• CHARLES RIVER LABORA — $250 across 0 shipments (0.0% of this supplier's total exports)

• CERGENTIS B.V. — $30 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: CORSANTRUM TECHNOLOGY's per-shipment value of $26.2K is 66% above the market average of $15.9K, consistent with large-order contracts or value-added formulations.

3VAMA LIFECARE PRIVATE LIMITED

VAMA LIFECARE PRIVATE LIMITED is the third-largest Nivolumab exporter from India, with a market share of 9.5% and a total export value of $217.8K across 7 shipments. Their average shipment value of $31.1K is above the market average of $15.9K, suggesting premium or bulk contract pricing.

VAMA LIFECARE PRIVATE LIMITED serves 1 named buyer in our database. COREX LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• COREX LLC — $217.8K across 7 shipments (100.0% of this supplier's total exports)

Key Insight: VAMA LIFECARE PRIVATE LIMITED's per-shipment value of $31.1K is 96% above the market average of $15.9K, consistent with large-order contracts or value-added formulations.

4MODERN DRUG HOUSE

MODERN DRUG HOUSE is the fourth-largest Nivolumab exporter from India, with a market share of 3.3% and a total export value of $74.3K across 15 shipments. Their average shipment value of $5.0K is below the market average of $15.9K, reflecting a high-volume, competitive pricing strategy.

MODERN DRUG HOUSE serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• JAIR CARLOS DE ARAUJO — $30.5K across 6 shipments (41.0% of this supplier's total exports)

• FRANCISCO EUDES DA SILVA — $11.8K across 2 shipments (15.9% of this supplier's total exports)

• ELIZETE DE OLIVEIRA DA SILVA — $11.8K across 2 shipments (15.9% of this supplier's total exports)

• RINEA IVETE ROOS BOER — $11.2K across 2 shipments (15.1% of this supplier's total exports)

• MARIA DE FATIMA ROCH — $8.9K across 2 shipments (12.0% of this supplier's total exports)

Key Insight: MODERN DRUG HOUSE operates with high shipment frequency (15 shipments) at a per-shipment value of $5.0K, indicating a broad distribution network with many smaller, regular orders.

5SPECIALITY MEDICINES LIMITED

SPECIALITY MEDICINES LIMITED is the fifth-largest Nivolumab exporter from India, with a market share of 3.2% and a total export value of $72.9K across 10 shipments. Their average shipment value of $7.3K is below the market average of $15.9K, reflecting a high-volume, competitive pricing strategy.

SPECIALITY MEDICINES LIMITED serves 1 named buyer in our database. AS PER INVOICE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• AS PER INVOICE — $72.9K across 10 shipments (100.0% of this supplier's total exports)

Key Insight: SPECIALITY MEDICINES LIMITED operates with high shipment frequency (10 shipments) at a per-shipment value of $7.3K, indicating a broad distribution network with many smaller, regular orders.

6RBN MEDITECH PRIVATE LIMITED

RBN MEDITECH PRIVATE LIMITED is the fifth-largest Nivolumab exporter from India, with a market share of 1.2% and a total export value of $27.6K across 12 shipments. Their average shipment value of $2.3K is below the market average of $15.9K, reflecting a high-volume, competitive pricing strategy.

RBN MEDITECH PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF- — $10.9K across 5 shipments (39.5% of this supplier's total exports)

• TO THE ORDER OF- — $8.9K across 4 shipments (32.2% of this supplier's total exports)

• TO THE ORDER OF- — $4.4K across 2 shipments (16.1% of this supplier's total exports)

• TO THE ORDER OF- — $2.2K across 1 shipments (8.1% of this supplier's total exports)

• DR TSUTOMU TAKEDA — $1.1K across 0 shipments (4.1% of this supplier's total exports)

Key Insight: RBN MEDITECH PRIVATE LIMITED operates with high shipment frequency (12 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.

1Singapore

Singapore ranks as the first-largest destination for Nivolumab imports from India, with a total trade value of $1.1M across 2 shipments — representing a 46.0% share of all Nivolumab exports. The average shipment value of $525.6K is above the global average of $15.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Nivolumab importers in Singapore: ALMAC PHARMACEUTICAL SERVICES PTE LIMITED is the largest buyer, accounting for 100.0% ($1.1M) of this market's total imports.

• ALMAC PHARMACEUTICAL SERVICES PTE LIMITED — $1.1M (100.0% of Singapore's total)

Key Insight: Singapore's per-shipment average of $525.6K (3216% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Singapore is a key market for Nivolumab imports from India.

Primary Market

Secondary Market

2Russia

Russia ranks as the second-largest destination for Nivolumab imports from India, with a total trade value of $773.4K across 8 shipments — representing a 33.9% share of all Nivolumab exports. The average shipment value of $96.7K is above the global average of $15.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Nivolumab importers in Russia: COREX LLC is the largest buyer, accounting for 100.0% ($773.4K) of this market's total imports.

• COREX LLC — $773.4K (100.0% of Russia's total)

Key Insight: Russia's per-shipment average of $96.7K (510% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Nivolumab imports from India.

Primary Market

Secondary Market

3Brazil

Brazil ranks as the third-largest destination for Nivolumab imports from India, with a total trade value of $280.5K across 23 shipments — representing a 12.3% share of all Nivolumab exports. The average shipment value of $12.2K is below the global average of $15.9K, consistent with generic/API volume purchasing. This market is served by 7 tracked buyers.

Named Nivolumab importers in Brazil: AS PER INVOICE is the largest buyer, accounting for 26.0% ($72.9K) of this market's total imports.

• AS PER INVOICE — $72.9K (26.0% of Brazil's total)

• JAIR CARLOS DE ARAUJO — $30.5K (10.9% of Brazil's total)

• FRANCISCO EUDES DA SILVA — $11.8K (4.2% of Brazil's total)

Key Insight: Brazil receives frequent, smaller shipments of Nivolumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Brazil is a key market for Nivolumab imports from India.

Primary Market

Secondary Market

4Seychelles

Seychelles ranks as the fourth-largest destination for Nivolumab imports from India, with a total trade value of $56.6K across 4 shipments — representing a 2.5% share of all Nivolumab exports. The average shipment value of $14.2K is below the global average of $15.9K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Nivolumab importers in Seychelles: HEALTH CARE AGENCY is the largest buyer, accounting for 38.4% ($21.7K) of this market's total imports.

• HEALTH CARE AGENCY — $21.7K (38.4% of Seychelles's total)

• INVOICE RAISED TO SEYCHELLES — $11.8K (20.8% of Seychelles's total)

Key Insight: Seychelles receives frequent, smaller shipments of Nivolumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Seychelles is a key market for Nivolumab imports from India.

Primary Market

Secondary Market

5Maldives

Maldives ranks as the fifth-largest destination for Nivolumab imports from India, with a total trade value of $54.8K across 11 shipments — representing a 2.4% share of all Nivolumab exports. The average shipment value of $5.0K is below the global average of $15.9K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Nivolumab importers in Maldives: STATE TRADING ORGANIZATION PLC is the largest buyer, accounting for 58.9% ($32.3K) of this market's total imports.

• STATE TRADING ORGANIZATION PLC — $32.3K (58.9% of Maldives's total)

• INDIRA GANDHI MEMORIAL HOSPITAL — $12.0K (22.0% of Maldives's total)

Key Insight: Maldives receives frequent, smaller shipments of Nivolumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Maldives is a key market for Nivolumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Nivolumab.
2.Flow Mapping: 23 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 144 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 13 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

144 Verified Shipments

23 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Nivolumab

Nivolumab

Who Supplies Nivolumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Nivolumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Nivolumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1DR.REDDY'S LABORATORIES LTD

2CORSANTRUM TECHNOLOGY

3VAMA LIFECARE PRIVATE LIMITED

4MODERN DRUG HOUSE

5SPECIALITY MEDICINES LIMITED

6RBN MEDITECH PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Nivolumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Nivolumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Singapore

2Russia

3Brazil

4Seychelles

5Maldives

People Also Ask — Nivolumab Supplier & Trade Network

Nivolumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology